4.7 Article

Facile Preparation of Macromolecular Prodrugs for Hypoxia-Specific Chemotherapy

期刊

ACS MACRO LETTERS
卷 9, 期 11, 页码 1687-1692

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmacrolett.0c00759

关键词

-

资金

  1. Deakin University
  2. CSIRO
  3. Natural Sciences and Engineering Council of Canada

向作者/读者索取更多资源

Hypoxia-activated prodrugs (HAPs) have emerged as important candidates for chemotherapy due to their efficient killing of hypoxic cancer cells. Traditional small molecule agents, such as tirapazamine (TPZ) and its derivatives, have shown unsatisfactory therapeutic effect in clinical trials due to poor bioavailability in hypoxic tumor regions. Herein, an amphiphilic macromolecular prodrug with hypoxia-specific activity, named as hypoxia-activated macromolecular prodrug (HAMP), is prepared from poly{[poly(ethylene glycol) methacrylate]-st-(methacrylic acid)} [poly(PEGMA-st-MAA)], containing pendant TPZ residues. This polymer can self-assemble in an aqueous system into similar to 37 nm sized nanoparticles. In vitro experiments indicated that HAMP shows 5x higher cytotoxicity to hypoxic cancer cells as compared to normoxic cancer cells. Therefore, the developed HAMP can be concurrently used with other therapeutic agents as a highly efficient hypoxia-activated agent.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据